UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

Annals of oncology, 2021-09, Vol.32 (9), p.1148-1156

2021

Volltextzugriff (PDF)

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Annals of oncology, 2018-02, Vol.29 (2), p.405-417

2018

Volltextzugriff (PDF)

Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer

Breast cancer research and treatment, 2021-01, Vol.185 (1), p.183-194

2021

Volltextzugriff (PDF)

Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the breast cancer treatment landscape

ESMO open, 2021-08, Vol.6 (4), p.100204, Article 100204

2021

Volltextzugriff (PDF)

Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate

Annals of oncology, 2022-03, Vol.33 (3), p.347-349

2022

Volltextzugriff (PDF)

Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer

Breast cancer research and treatment, 2022-04, Vol.192 (2), p.293-301

2022

Volltextzugriff (PDF)

Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors

Supportive care in cancer, 2018-03, Vol.26 (3), p.869-878

2018

Volltextzugriff (PDF)

Scalp cooling in breast cancer patients treated with docetaxel–cyclophosphamide: patient- and nurse-reported results

Breast cancer research and treatment, 2021-04, Vol.186 (3), p.715-722

2021

Volltextzugriff (PDF)

ESMO20 YO for YO: highlights on new drugs in advanced breast cancer focusing on sacituzumab govitecan and alpelisib

ESMO open, 2021-02, Vol.6 (1), p.100018-100018, Article 100018

2021

Volltextzugriff (PDF)

ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer

ESMO open, 2021-02, Vol.6 (1), p.100017-100017, Article 100017

2021

Volltextzugriff (PDF)

Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer

Breast cancer research and treatment, 2018-08, Vol.171 (1), p.131-141

2018

Volltextzugriff (PDF)

Risk-reducing mastectomy in BRCA carriers: survival is not the issue

Breast cancer research and treatment, 2020, Vol.179 (1), p.251-252

2020

Volltextzugriff (PDF)

Corrigendum to “Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer”: [Annals of Oncology 33 (2022) 769–785]

Annals of oncology, 2023-03, Vol.34 (3), p.326-326

2023

Volltextzugriff (PDF)

Intrahepatic mitomycin C infusion in breast cancer liver metastases

Annals of oncology, 2019-05, Vol.30, p.iii57-iii58

2019

Volltextzugriff (PDF)

Differences between breast cancer subtypes in developing metastatic disease

Annals of oncology, 2019-05, Vol.30, p.iii50-iii50

2019

Volltextzugriff (PDF)

The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration

ESMO open, 2021-04, Vol.6 (2), p.100058, Article 100058

2021

Volltextzugriff (PDF)

Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival

Breast cancer research and treatment, 2019-08, Vol.176 (3), p.597-605

2019

Volltextzugriff (PDF)

The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series

ESMO open, 2022-02, Vol.7 (1), p.100374, Article 100374

2022

Volltextzugriff (PDF)

ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology

ESMO open, 2024-10, Vol.9 (10), p.103634, Article 103634

2024

Volltextzugriff (PDF)

Real-world treatment patterns and outcomes in patients with HR+/HER2− metastatic breast cancer treated with chemotherapy in the United States

ESMO open, 2024-09, Vol.9 (9), p.103691, Article 103691

2024

Volltextzugriff (PDF)

The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II

ESMO open, 2021-08, Vol.6 (4), p.100199-100199, Article 100199

2021

Volltextzugriff (PDF)

Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort

Journal of cancer research and clinical oncology, 2021-04, Vol.147 (4), p.1041-1048

2021

Volltextzugriff (PDF)

Breast cancer subtype and survival by parity and time since last birth

Breast cancer research and treatment, 2018-06, Vol.169 (3), p.481-487

2018

Volltextzugriff (PDF)

COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

ESMO open, 2023-06, Vol.8 (3), p.101566-101566, Article 101566

2023

Volltextzugriff (PDF)

Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3

ESMO open, 2021-08, Vol.6 (4), p.100203-100203, Article 100203

2021

Volltextzugriff (PDF)

1 – 25 von 105

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(102)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(105)

Sprache

Englisch
(105)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Annals Of Oncology
(35)
Esmo Open
(23)
Cancer Research
(12)
Breast Cancer Research And Treatment
(7)
Nature Communications
(6)
European Journal Of Cancer
(5)
Acta Clinica Belgica
(1)
Breast Cancer Research
(1)
Breast Cancer Research : Bcr
(1)
Cancer
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Efficacy of anti-HER2 therapy in metastatic breast cancer by discordance of HER2 expression between primary and metastatic breast cancer

Sacituzumab govitecan and trastuzumab deruxtecan: two new antibody–drug conjugates in the breast cancer treatment landscape

Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate

Preventing taxane-related peripheral neuropathy, pain and nail toxicity: a prospective self-controlled trial comparing hilotherapy with frozen gloves in early breast cancer

Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors

Scalp cooling in breast cancer patients treated with docetaxel–cyclophosphamide: patient- and nurse-reported results

ESMO20 YO for YO: highlights on new drugs in advanced breast cancer focusing on sacituzumab govitecan and alpelisib

ESMO20 YO for YO: highlights on immune checkpoint blockade for triple-negative breast cancer

Palbociclib in highly pretreated metastatic ER-positive HER2-negative breast cancer

Risk-reducing mastectomy in BRCA carriers: survival is not the issue

Corrigendum to “Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer”: [Annals of Oncology 33 (2022) 769–785]

Intrahepatic mitomycin C infusion in breast cancer liver metastases

Differences between breast cancer subtypes in developing metastatic disease

The impact of COVID-19 on oncology professionals: results of the ESMO Resilience Task Force survey collaboration

Intra-arterial Mitomycin C infusion in a large cohort of advanced liver metastatic breast cancer patients: safety, efficacy and factors influencing survival

The impact of COVID-19 on oncology professionals—one year on: lessons learned from the ESMO Resilience Task Force survey series

ESMO Resilience Task Force recommendations to manage psychosocial risks, optimise well-being, and reduce burnout in oncology

Real-world treatment patterns and outcomes in patients with HR+/HER2− metastatic breast cancer treated with chemotherapy in the United States

The concerns of oncology professionals during the COVID-19 pandemic: results from the ESMO Resilience Task Force survey II

Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohort

Breast cancer subtype and survival by parity and time since last birth

COVID-19 in cancer patients: update from the joint analysis of the ESMO-CoCARE, BSMO, and PSMO international databases

Detection of secondary metastatic breast cancer by measurement of plasma CA 15.3

Suchergebnisse filtern